ENDOMETRIOSIS TEST FOR PATIENTS
The first part of the EndoSure Test is an EGG/EVG analysis. This fast and comfortable Test is conducted using an advanced medical device called the TRICORDER-3L. Three sensor pads are precisely placed on the abdomen and the patient drinks a glass of water and reclines for 30 minutes.
The TRICORDER-3L detects myoelectric signals from the abdomen and pelvis. Research has found that there is a unique myoelectric signature from the smooth muscle of the gastrointestinal tract triggered by the presence of endometriosis anywhere in the anatomy. when compared to patients without endometriosis.²
Calculations using the patient-specific data from the TRICORDER-3L are performed using the EndoSure support software. The resulting data is provided to the physician as a quantified value, and can be used in combination with other clinical information to support the diagnosis of endometriosis.
Within 30 minutes, your physician will have the EndoSure Test* results to confirm or eliminate the presence of endometriosis.
ABOUT US
ENDOSURE, INC. offers the only non-invasive, 30-minute, highly accurate diagnosis test for endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.*
© February 2025 ENDOSURE, INC. All rights reserved
1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.
2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
3. i. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024 May 13;13(10):2866. doi: 10.3390/jcm13102866. PMID: 38792407; PMCID: PMC11122642.
4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.
5. 1. Noar M, Mathias J, Kolatkar A. Validation of New GIMA Biomarker Signature of Endometriosis - Interim Data: Research Article. TechRxiv. August 26, 2024. DOI: 10.22541/au.172469630.08159498/v1
6. 1. Kitsantas P, Benson KN, Al-Farauki S, Knecht MK, Hennekens CH, et al. (2024) Emerging Diagnostic Tools for the Early Diagnosis of Endometriosis. J Reprod Med Gynecol Obstet 9: 171.
DISCLAIMER: THE ENDOSURE TEST IS A DIAGNOSTIC TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH IS INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.
* USA CUSTOMERS: EndoSure is currently available for research in the USA use only and not clinical use.